GBP2 and melanoma: We successfully separated the TCGA-melanoma samples into two subtypes on the basis of the expression of the ICD-related genes and developed a prognostic ICDRS involving 3 genes (i.e., GBP2, THBS4, and APOBEC3G) based on the DEGs between the two subtypes.